Microarrays: The use of oligonucleotides and cDNA for the analysis of gene expression

Drug Discovery Today

Volumn 8, Issue 3, 2003, Pages 134-141

  Barrett, J Carl ^a   Kawasaki, Ernest S ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; OLIGONUCLEOTIDE;

BIOTECHNOLOGY; COST EFFECTIVENESS ANALYSIS; DNA LIBRARY; DNA MICROARRAY; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC COMPLEMENTATION; HUMAN; HUMAN GENOME; POLYMERASE CHAIN REACTION; QUALITY CONTROL; REVIEW; SEQUENCE ANALYSIS;

ANIMALS; DNA, COMPLEMENTARY; GENE EXPRESSION; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OLIGONUCLEOTIDES;

EID: 0037458085     PISSN: 13596446     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1359-6446(02)02578-3     Document Type: Review

References (76)

1. Venter J.C., et al. The sequence of the human genome. Science. 291:2001;1303-1351.
2. Lander E.S., et al. Initial sequencing and analysis of the human genome. Nature. 409:2001;860-921.
3. Genome sequence of the nematode C. elegans: a platform for investigating biology. Science. 282:1998;2012-2018.
4. Yu J., et al. A draft sequence of the rice genome (Oryza sativa L. ssp. Indica). Science. 296:2002;79-92.
5. Goff S.A., et al. A draft sequence of the rice genome (Oryza sativa L. ssp. Japonica). Science. 296:2002;92-100.
6. Schena M., et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 270:1995;467-470.
7. Ekins R., Chu F.W. Microarrays: their origins and applications. Trends Biotechnol. 17:1999;217-218.
8. Ekins R., et al. High specific activity chemiluminescent and fluorescent markers: their potential application to high sensitivity and 'multi-analyte' immunoassays. J. Biolumin. Chemilumin. 4:1989;59-78.
9. Ekins R.P. Multi-analyte immunoassay. J. Pharm. Biomed. Anal. 7:1989;155-168.
10. Hayward R.E., et al. Probing the proteome - protein arrays and their applications. Drug Discov. Today. 6:2001;1263-1264.
11. Mitchell P. A perspective on protein microarrays. Nat. Biotechnol. 20:2002;225-229.
12. Templin M.F., et al. Protein microarray technology. Trends Biotechnol. 20:2002;160-166.
13. Petricoin E.F., et al. Clinical proteomics: translating benchside promise into bedside reality. Nat. Rev. Drug Discov. 1:2002;683-695.
14. MacBeath G. Protein arrays and proteomics. Nat. Genet. 32:(Suppl.):2002;526-532.
15. Schena M., et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc. Natl. Acad. Sci. U. S. A. 93:1996;10614-10619.
16. Duggan D.J., et al. Expression profiling using cDNA microarrays. Nat. Genet. 21:(Suppl.):1999;10-14.
17. Winzeler E.A., et al. Fluorescence-based expression monitoring using microarrays. Methods Enzymol. 306:1999;3-18.
18. Lou X.J., et al. Expression monitoring using cDNA microarrays. Methods Mol. Biol. 175:2001;323-340.
19. Fodor S.P.A., et al. Light-directed, spatially addressable parallel chemical synthesis. Science. 251:1991;767-773.
20. Lockhart D.J., et al. Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat. Biotechnol. 14:1996;1675-1680.
21. Lipshutz R.J., et al. High density synthetic oligonucleotide arrays. Nat. Genet. 21:(Suppl):1999;20-24.
22. Singh-Gasson S., et al. Maskless fabrication of light-directed oligonucleotide microarrays using a digital micromirror array. Nat. Biotechnol. 17:1999;974-978.
23. Cerrina F., et al. Biological lithography: development of a maskless microarray synthesizer for DNA chips. Microelectron. Eng. 61-62:2002;33-40.
24. Nuwaysir E.F., et al. Gene expression analysis using oligonucleotide arrays produced by maskless photolithography. Genome Res. 12:2002;1749-1755.
25. Blanchard A.P., et al. High-density oligonucleotide arrays. Biosens. Bioelectron. 11:1996;687-690.
26. Hughes T.R., et al. Expression profiling using microarrays fabricated by an ink-jet oligonucleotide synthesizer. Nat. Biotechnol. 19:2001;342-347.
27. van Veer A., et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature. 415:2002;530-536.
28. Chambers J., et al. DNA microarrays of the complex human cytomegalovirus genome: profiling kinetic class with drug sensitivity of viral gene expression. J. Virol. 73:1999;5757-5766.
29. Beaucage S.L. Strategies in the preparation of DNA oligonucleotide arrays for diagnostic applications. Curr. Med. Chem. 8:2001;1213-1244.
30. Dudley A.M., et al. Measuring absolute expression with microarrays with a calibrated reference sample and an extended signal intensity range. Proc. Natl. Acad. Sci. U. S. A. 99:2002;7554-7559.
31. Relogio A., et al. Optimization of oligonucleotide-based DNA microarrays. Nucleic Acids Res. 30:2002;e51.
32. El Atifi M., et al. Long oligonucleotide arrays on nylon for large-scale gene expression analysis. BioTechniques. 33:2002;612-618.
33. Wang R-F., et al. Design and evaluation of oligonucleotide-microarray method for the detection of human intestinal bacteria in fecal samples. FEMS Microbiol. Lett. 213:2002;175-182.
34. Wagner E.K., et al. Practical approaches to long oligonucleotide-based DNA microarray: lessons from Herpesviruses. Prog. Nucleic Acid Res. Mol. Biol. 71:2002;445-491.
35. Stingley S.W., et al. Global analysis of herpes simplex virus type I transcription using an oligonucleotide-based DNA microarray. J. Virol. 74:2000;9916-9927.
36. Yang W.C., et al. General and specific alterations in programming of global viral gene expression during infection by VP16 activation-deficient mutants of herpes simplex virus type I. J. Virol. 76:2002;12758-12774.
37. Wang D., et al. Microarray-based detection and genotyping of viral pathogens. Proc. Natl. Acad. Sci. U. S. A. 99:2002;15687-15692.
38. Li F., Stormo G.D. Selection of optimal DNA oligos for gene expression arrays. Bioinformatics. 17:2001;1067-1076.
39. Rouillard J-M., et al. OligoArray: genome-scale oligonucleotide design for microarrays. Bioinformatics. 18:2002;486-487.
40. Chen H., Sharp B.M. Oliz, a suite of Perl scripts that assist in the design of microarrays using 50 mer oligonucleotides from the 3′ untranslated region. BMC Bioinformatics. 3:2002;27.
41. Wright M.A., Church G.M. An open-source oligomicroarray standard for human and mouse. Nat. Biotechnol. 20:2002;1082-1083.
42. Taniguchi M., et al. Quantitative assessment of DNA microarrays - comparison with Northern blot analyses. Genomics. 71:2001;34-39.
43. O'Connell J. RT-PCR in biomedicine. Opportunities arising from the new accessibility of mRNA. Methods Mol. Biol. 193:2002;3-17.
44. Bustin S.A. Absolute quantitation of mRNA using real-time reverse transcription polymerase chain reaction assays. J. Mol. Endocrinol. 25:2000;169-193.
45. Aach J., et al. Systematic management and analysis of yeast gene expression data. Genome Res. 10:2000;431-445.
46. Quackenbush J. Computational analysis of microarray data. Nat. Rev. Genet. 2:2001;418-427.
47. Nadon R., Shoemaker J. Statistical issue with microarrays: processing and analysis. Trends Genet. 18:2002;265-271.
48. Brazma A., et al. Microarray data representation, annotation and storage. Adv. Biochem. Eng. Biotechnol. 77:2002;113-139.
49. Holloway A.J., et al. Options available - from start to finish - for obtaining data from DNA microarrays II. Nat. Genet. 32:(Suppl.):2002;481-489.
50. Churchill G.A. Fundamentals of experimental design for cDNA microarrays. Nat. Genet. 32:(Suppl.):2002;490-495.
51. Quackenbush J. Microarray data normalization and transformation. Nat. Genet. 32:(Suppl.):2002;496-501.
52. Brazma A., et al. Minimum information about a microarray experiment (MIAME) - towards standards for microarray data. Nat. Genet. 29:2001;365-371.
53. Stoeckert C.J. Jr, et al. Microarray databases: standards and ontologies. Nat. Genet. 32:(Suppl.):2002;469-473.
54. No author (2002) Microarray standards at last. Nature 419, 323.
55. Ball C., et al. Standards for microarray data. Science. 298:2002;539.
56. Kuo W.P., et al. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics. 18:2002;405-412.
57. Kothapalli R., et al. Microarray results: how accurate are they? BMC Bioinformatics. 3:2002;22.
58. Li J., et al. Differential gene expression patterns revealed by oligonucleotide versus long cDNA arrays. Toxicol. Sci. 69:2002;383-390.
59. Yuen T., et al. Accuracy and calibration of commercial oligonucleotide and custom cDNA arrays. Nucleic Acid Res. 30:2002;e48.
60. Rhodes D.R., et al. Meta-analysis of microarrays: interstudy validation of gene expression profiles reveals pathway disregulation in prostate cancer. Cancer Res. 62:2002;4427-4433.
61. Kane M.D., et al. Assessment of the sensitivity and specificity of oligonucleotide (50 mer) microarrays. Nucleic Acid Res. 28:2000;4552-4557.
62. Kerr M.K., Churchill G.A. Experimental design for gene expression microarrays. Biostatistics. 2:2001;183-201.
63. Yang Y.H., Speed T. Design issues for cDNA microarray experiments. Nat. Rev. Genet. 3:2002;579-588.
64. Simon R., et al. Design studies using DNA microarrays. Genet. Epidemiol. 23:2002;21-36.
65. Clark T.A., et al. Genomewide analysis of mRNA processing in yeast using splicing-specific microarrays. Science. 296:2002;907-910.
66. Maniatis T., Tasic B. Alternative pre-mRNA splicing and proteome expansion in metazoans. Nature. 418:2002;236-243.
67. Liang P. SAGE Genie: a suite with panoramic view of gene expression. Proc. Natl. Acad. Sci. U. S. A. 99:2002;11547-11548.
68. Evans S.J., et al. Evaluation of Affymetrix gene chip sensitivity in rat hippocampal tissue using SAGE analysis. Eur. J. Neurosci. 16:2002;409-413.
69. Patino W.D., et al. Serial analysis of gene expression: technical considerations and applications to cardiovascular biology. Circ. Res. 91:2002;565-569.
70. Soulet D., Rivest S. Perspective: how to make microarray, serial analysis of gene expression, and proteomic relevant to day-to-day endocrine problems and physiological systems. Endocrinololgy. 143:2002;1995-2001.
71. Somogyi R., Greller L.D. The dynamics of molecular networks: applications to therapeutic discovery. Drug Discov. Today. 6:2001;1267-1277.
72. Clarke P.A., et al. Gene expression microarray analysis in cancer biology, pharmacology, and drug development: progress and potential. Biochem. Pharmacol. 62:2001;1311-1336.
73. Ulrich R., Friend S.H. Toxigenomics and drug discovery: will new technologies help us produce better drugs? Nat. Rev. Drug Discov. 1:2002;84-88.
74. Hamadeh H.K., et al. Gene expression analysis reveals chemical-specific profiles. Toxicol. Sci. 67:2002;219-231.
75. Petricoin E.F. III, et al. Medical applications of microarray technologies: a regulatory science perspective. Nat. Genet. 32:(Suppl.):2002;474-479.
76. Gerhold D.L., et al. Better therapeutics through microarrays. Nat. Genet. 32:(Suppl.):2002;547-552.